Physical Exercise Versus Rosiglitazone in CAD and Prediabetes
NCT ID: NCT00675740
Last Updated: 2010-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
45 participants
INTERVENTIONAL
2004-01-31
2007-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Exercise on Insulin Resistance
NCT01941277
Type 2 Diabetes Post Exercise Arterial Stiffness
NCT06438874
Effects of Physical Exercise in Type 2 Diabetics
NCT01095068
Profile and Regulatory Network of Exercise in Improving Metabolic Phenotypes of Patients with Prediabetes
NCT06633575
Role of Interleukin-6 in Exercise
NCT01073826
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
rosiglitazone
tablets 4 mg daily
2
physical exercise
physical exercise
stationary bike 5-6 times a week
3
control
control
control without intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rosiglitazone
tablets 4 mg daily
physical exercise
stationary bike 5-6 times a week
control
control without intervention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* angiographic evidence of coronary artery disease
Exclusion Criteria
* preexisting antidiabetic medication
* unstable angina
* indication for coronary bypass surgery
* significant left main disease
* myocardial infarction within preceding 3 months
* ejection fraction \< 40%
* significant heart valve disease
* severe metabolic disorders
* severe disorders in lipoprotein metabolism
* thyroid disorders
* alcohol or drug abuse
* pregnancy
* participation in another trial
35 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Leipzig
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Leipzig
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Leipzig 03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.